Burns, AU
Alan Robert Burns, Dalkeith AU
Patent application number | Description | Published |
---|---|---|
20100314014 | TYRE | 12-16-2010 |
Alan Robert Burns, Western Australia AU
Patent application number | Description | Published |
---|---|---|
20090107328 | Reciprocating Pump - A reciprocating pump ( | 04-30-2009 |
20100171312 | BUOYANT ACTUATOR - A buoyant actuator ( | 07-08-2010 |
20100219065 | WAVE ENGERGY CONVERSION - Apparatus ( | 09-02-2010 |
20120102938 | BOUYANT ACTUATOR - A buoyant actuator ( | 05-03-2012 |
Alexander Jeffrey Burns, Willetton AU
Patent application number | Description | Published |
---|---|---|
20090301720 | REMOTE PLUGGING DEVICE FOR WELLS - Remote cement plugging device ( | 12-10-2009 |
Ben Burns, Sapphire Beach AU
Patent application number | Description | Published |
---|---|---|
20160053917 | CONDUIT HANGER - A conduit hanger includes a base. At least one carrier extends from the base. The carrier(s) define a retaining formation in which a respective conduit can be received. The base and the carrier(s) are formed from at least one flat sheet of material. At least one obstruction member is mounted on one of the base and the, or each respective, carrier and is displaceable between an inoperative position in which the conduit can be removed from the respective carrier and an operative position in which the conduit is retained in the respective carrier with the obstruction member. | 02-25-2016 |
Christopher J. Burns, Caulfield AU
Patent application number | Description | Published |
---|---|---|
20150018350 | N-CONTAINING HETEROCYCLIC COMPOUNDS - The present invention relates to N-containing heterocyclic compounds that are inhibitors of protein kinases including JAK kinases. In particular, the compounds are selective for JAK1, JAK2, JAK3 or TYK2 kinases and combinations thereof such as JAK1 and JAK2. The kinase inhibitors can be used in the treatment of kinase associated diseases such as immunological and inflammatory diseases including organ transplants; hyperproliferative diseases including cancer and myeloproliferative diseases; viral diseases; metabolic diseases; and vascular diseases. | 01-15-2015 |
Christopher John Burns, Caulfield North AU
Patent application number | Description | Published |
---|---|---|
20140005161 | PHENYL AMINO PYRIMIDINE BICYCLIC COMPOUNDS AND USES THEREOF | 01-02-2014 |
20140045848 | THIOPYRIMIDINE-BASED COMPOUNDS AND USES THEREOF - The present invention relates to thiopyrimidine-based compounds that are inhibitors of protein kinases including JAK kinases. In particular, the compounds are selective for JAK1, JAK2 or JAK3 kinases and combinations thereof such as JAK1 and JAK2. The kinase inhibitors can be used in the treatment of kinase associated diseases such as immunological and inflammatory diseases including organ transplants; hyperproliferative diseases including cancer and myeloproliferative diseases; viral diseases; metabolic diseases and vascular diseases. | 02-13-2014 |
20140051703 | THIOPYRIMIDINE-BASED COMPOUNDS AND USES THEREOF - The present invention relates to thiopyrimidine-based compounds that are inhibitors of protein kinases including JAK kinases. In particular, the compounds are selective for JAK1, JAK2 or JAK3 kinases and combinations thereof such as JAK1 and JAK2. The kinase inhibitors can be used in the treatment of kinase associated diseases such as immunological and inflammatory diseases including organ transplants; hyperproliferative diseases including cancer and myeloproliferative diseases; viral diseases; metabolic diseases and vascular diseases. | 02-20-2014 |
20140171433 | MULTIPLE MYELOMA TREATMENT - A method of treating a subject presenting with multiple myeloma at a stage characterized by an increase in the prevalence of MM cells that (1) are IL-6 non-responsive and/or (2) have a CD45− phenotype, comprising administering to the subject an amount of a compound of formula Ib. | 06-19-2014 |
20140221396 | TUBULIN INHIBITORS - Compounds of general formula (I), (II), (III) and (V) are described for use in modulating microtubule polymerisation and in the treatment of associated disease states. Use of compounds (I), (III) and (V) in the treatment of kinase-associated disease states is also described. Further described are novel compounds of formula (II), (III) and (V). | 08-07-2014 |
Christopher John Burns, Richmond, Victoria AU
Christopher John Burns, Melbourne AU
Patent application number | Description | Published |
---|---|---|
20110092499 | N-CONTAINING HETEROCYCLIC COMPOUNDS - The present invention relates to N-containing heterocyclic compounds that are inhibitors of protein kinases including JAK kinases. In particular, the compounds are selective for JAK1, JAK2, JAK3 or TYK2 kinases and combinations thereof such as JAK1 and JAK2. The kinase inhibitors can be used in the treatment of kinase associated diseases such as immunological and inflammatory diseases including organ transplants; hyperproliferative diseases including cancer and myeloproliferative diseases; viral diseases; metabolic diseases; and vascular diseases. | 04-21-2011 |
Christopher John Burns, Richmond AU
Patent application number | Description | Published |
---|---|---|
20100130447 | INHIBITORS OF KINASE ACTIVITY - The present invention relates to pyridines or pyrazines that inhibit kinases. In particular the compounds of the invention inhibit members of the class III PTK receptor family such as FMS (CSF-IR), c-KIT, PDGFRβ, PDGFRα or FLT3 and KDR, SRC, EphA2, EphA3, EphA8, FLT1, FLT4, HCK, LCK, PTK5 (FRK), SYK, DDR1 and DDR2 and RET. The compounds of the invention are useful in the treatment of kinase associated diseases such as immunological and inflammatory diseases; hyperproliferative diseases including cancer and diseases involving neo-angiogenesis; renal and kidney diseases; bone remodeling diseases; metabolic diseases; and vascular diseases. | 05-27-2010 |
20100197671 | PHENYL AMINO PYRIMIDINE COMPOUNDS AND USES THEREOF - The present invention relates to phenyl amino pyrimidine compounds which are inhibitors of protein kinases including JAK kinases. In particular the compounds are selective for JAK2 kinases. The kinase inhibitors can be used in the treatment of kinase associated diseases such as immunological and inflammatory diseases including organ transplants; hyperproliferative diseases including cancer and myeloproliferative diseases; viral diseases; metabolic diseases; and vascular diseases. | 08-05-2010 |
20100239631 | THIOPYRIMIDINE-BASED COMPOUNDS AND USES THEREOF - The present invention relates to thiopyrimidine-based compounds that are inhibitors of protein kinases including JAK kinases. In particular, the compounds are selective for JAK1, JAK2 or JAK3 kinases and combinations thereof such as JAK1 and JAK2. The kinase inhibitors can be used in the treatment of kinase associated diseases such as immunological and inflammatory diseases including organ transplants; hyperproliferative diseases including cancer and myeloproliferative diseases; viral diseases; metabolic diseases and vascular diseases. | 09-23-2010 |
20110082142 | SELECTIVE KINASE INHIBITORS - A compound of the general formula (I) or pharmaceutically acceptable prodrugs, salts, hydrates, solvates, crystal forms or diastereomers thereof, wherein A represents a variety of six membered nitrogen containing heterocyclic rings, Q is a bond, halogen, C | 04-07-2011 |
20130090336 | N-CONTAINING HETEROCYCLIC COMPOUNDS - The present invention relates to N-containing heterocyclic compounds that are inhibitors of protein kinases including JAK kinases. In particular, the compounds are selective for JAK1, JAK2, JAK3 or TYK2 kinases and combinations thereof such as JAK1 and JAK2. The kinase inhibitors can be used in the treatment of kinase associated diseases such as immunological and inflammatory diseases including organ transplants; hyperproliferative diseases including cancer and myeloproliferative diseases; viral diseases; metabolic diseases; and vascular diseases. | 04-11-2013 |
20130137660 | INHIBITORS OF KINASE ACTIVITY - The present invention relates to pyridines or pyrazines that inhibit kinases. In particular the compounds of the invention inhibit members of the class III PTK receptor family such as FMS (CSF-IR), c-KIT, PDGFRβ, PDGFRα or FLT3 and KDR, SRC, EphA2, EphA3, EphA8, FLT1, FLT4, HCK, LCK, PTK5 (FRK), SYK, DDR1 and DDR2 and RET. The compounds of the invention are useful in the treatment of kinase associated diseases such as immunological and inflammatory diseases; hyperproliferative diseases including cancer and diseases involving neo-angiogenesis; renal and kidney diseases; bone remodeling diseases; metabolic diseases; and vascular diseases. | 05-30-2013 |
20130274263 | TUBULIN INHIBITORS | 10-17-2013 |
20140005180 | PHENYL AMINO PYRIMIDINE COMPOUNDS AND USES THEREOF | 01-02-2014 |
Christopher John Burns, North Caulfield AU
Patent application number | Description | Published |
---|---|---|
20090281119 | ACID ADDITION SALTS OF N-ETHYI-N'-[2-METHOXY-4-(5-METHYI-4-PRYIMIDIN-2-YL)PHENYL]UREA AND USES THEREOF - The present invention provides an acid addition salt of N-ethyl-N′-[2-methoxy-4-(5-methyl-4-{[(1S)-1-pyridin-3-ylbutyl]amino}pyrimidin-2-yl)phenyl]urea and uses thereof including a method for the treatment of a hyperproliferation-related disorder. The present invention also provides a pharmaceutical composition comprising an acid addition salt of N-ethyl-N′-[2-methoxy-4-(5-methyl-4-{[(1S)-1-pyridin-3-ylbutyl]amino}pyrimidin-2-yl)phenyl]urea. | 11-12-2009 |
Christopher John Burns, Victoria AU
Patent application number | Description | Published |
---|---|---|
20080207613 | Selective Kinase Inhibitors - A compound of the general formula (I) or pharmaceutically acceptable prodrugs, salts, hydrates, solvates, crystal forms or diastereomers thereof, wherein A represents a variety of six membered nitrogen containing heterocyclic rings, Q is a bond, halogen, C | 08-28-2008 |
Christopher John Burns, Seddon AU
Patent application number | Description | Published |
---|---|---|
20110269760 | TUBULIN INHIBITORS - Compounds of general formula (I), (II), (III) and (V) are described for use in modulating microtubule polymerisation and in the treatment of associated disease states. Use of compounds (I), (III) and (V) in the treatment of kinase-associated disease states is also described. Further described are novel compounds of formula (II), (III) and (V). | 11-03-2011 |
Christopher John Burns, Notting Hill AU
Patent application number | Description | Published |
---|---|---|
20160031835 | TUBULIN INHIBITORS - Compounds of general formula (I), (II), (III) and (V) are described for use in modulating microtubule polymerisation and in the treatment of associated disease states. Use of compounds (I), (III) and (V) in the treatment of kinase-associated disease states is also described. Further described are novel compounds of formula (II), (III) and (V). | 02-04-2016 |
Gordon Frood Burns, New Lambton Heights AU
Patent application number | Description | Published |
---|---|---|
20130129734 | COMPOSITION AND METHODS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF LEUKEMIA - The present disclosure relates generally to compositions and methods for the diagnosis, prognosis and treatment of leukemia, in particular leukemia in which leukemic cells, or neoplastic precursors thereof, express Fat1 or a homolog of Fat1 that is substantially not expressed on normal blood cells. | 05-23-2013 |
Owen Burns, East Melbourne AU
Patent application number | Description | Published |
---|---|---|
20150251002 | ELECTRICAL APPARATUS AND METHODS AND APPARATUS FOR POSITIONING AND IMPLANTING COMPONENTS THEREOF - An anchor device is described that is adapted to support one or more conductors extending out of an opening in an outer surface of an eye, from a device implanted in the eye to a communications interface. The anchor device comprises a conductor receiving portion including a channel, the conductors being positionable through the channel; and a fixation portion connected to the conductor receiving portion, the fixation portion being adapted to be secured to the outer surface of the eye. The conductor receiving portion is configured to allow movement of the channel and/or conductors relative to the fixation portion. A visual prosthesis comprising the anchor device is also described, along with apparatus and methods for positioning the visual prosthesis or other types of implantable electrical apparatus. | 09-10-2015 |
Peter John Burns, Rose Bay AU
Patent application number | Description | Published |
---|---|---|
20130199545 | Mouth Guard - A mouth guard having a “C” shape is provided with a forward portion and a pair of rearwardly extending arms. The mouth guard includes a body that provides flanges as well as a base. Rear shields are embedded in the base portions of the arms, and the shields are preferably of a corrugated configuration so as to have ridges separated by troughs. | 08-08-2013 |
Phillip Anthony Burns, Cammeray AU
Patent application number | Description | Published |
---|---|---|
20120278341 | DOCUMENT ANALYSIS AND ASSOCIATION SYSTEM AND METHOD - Methods and systems for indexing a plurality of documents, each document comprising a text portion, the method parses the text portion of each of the plurality of documents to form a plurality of respective local document indexes each associated with a respective document, and stores the local document index in a database, Each local document index has a plurality of local text terms and a local weighting associated with each text term From the plurality of local document indexes, forming a global document index associated with each global text term. The global weighting is determined with respect to a parameter associated with a reference global text term. Also, methods and systems for analyzing a text portion, retrieving documents from a database relevant to the text portion and for refining the results of a search are disclosed. | 11-01-2012 |
Steve Daniel Burns, Gooseberry Hill AU
Patent application number | Description | Published |
---|---|---|
20150101926 | Electrolytic Cell - An apparatus for producing a combustible gas for use in enhancing or supplementing a fuel supply of an internal combustion engine comprising an electrolytic cell defining a first electrolyte flow path from an upper chamber to a lower chamber and a second electrolysis gas flow path from the lower chamber to a gas trap disposed in the upper chamber. The gas trap arranged to be in fluid communication with an internal combustion engine intake manifold for supplying combustible electrolytic gases produced in the electrolytic cell apparatus to the fuel supply. Further disclosed is a system comprising an electrolyte flow circuit and control unit for use with the apparatus for maintaining optimal operational parameters of the electrolyte undergoing an electrolytic reaction. The system arranged to regulate a flow rate and temperature range of the electrolyte for improving production of combustible gases within the apparatus. | 04-16-2015 |
Wayne Alan Robert Burns, Paradise Point AU
Patent application number | Description | Published |
---|---|---|
20150068919 | CATHODIC PROTECTION SYSTEM - An impressed current cathodic protection system for a target structure susceptible to corrosion (such as of steel or cast iron) which comprises an inert mixed metal oxide anode surrounded by a tightly packed conductive zone connected to a power supply source and having an input/output regulator to control the flow of current to the target structure. The present invention relates to device and method to provide personal and/or medical details of one or more individuals in the event of an emergency. | 03-12-2015 |